In This Article:
picture alliance / Getty Images
Salesforce has “one of the healthiest long-term profitable growth stories," Oppenheimer analysts said ThursdayKey Takeaways
-
Salesforce is set to report quarterly results on Wednesday after the market closes.
-
A majority of analysts tracked by Visible Alpha have a "buy" or equivalent rating for the company's stock.
-
Salesforce's AI offering Agentforce is seeing "strong momentum," Oppenheimer analysts said.
Salesforce (CRM) is scheduled to report fiscal first-quarter results after the closing bell Wednesday, with analysts largely bullish on the cloud software company's stock.
Of the 23 analysts tracked by Visible Alpha, 18 have a “buy” or equivalent rating for the shares, with four “hold” ratings and one “sell.” Their consensus price target of about $364 would suggest 33% upside from Friday’s close. Shares of Salesforce are down about 18% for 2025 so far.
The customer relationship management software giant is expected to post first-quarter revenue of $9.75 billion, a roughly 7% jump year-over-year, and adjusted earnings per share of $2.55, up from $2.44 a year ago.
Oppenheimer called Salesforce “one of the healthiest long-term profitable growth stories” among software companies in a note to clients Thursday. While macro uncertainty raises risk, Salesforce’s AI platform Agentforce is seeing "strong momentum,” the analysts said, and maintained a target of $380.
Citi analysts took more of a wait-and-see approach to Agentforce. They lowered their price target to $320 from $335, saying they “await more meaningful data points” around the AI offering’s commercialization. Meanwhile, Deutsche Bank recently reiterated its more bullish target of $400, while Jefferies maintained its at $375.
Read the original article on Investopedia